Effects of mild-warming moxibustion on Bcl-2 and PKC expressions of peripheral blood in elderly people  by SHI, Yin et al.
TOPIC
JTCM |www. journaltcm. com March 15, 2012 | volume 32 | Issue 1 |
Online Submissions: http://www.journaltcm.com J Traditional Chinese Medicine 2012 March 15; 32(1): 45-51
info@journaltcm.com ISSN 0255-2922
© 2012 JTCM. All rights reserved.
Clinical Observation
SHI Yin, CUI Yun-hua, WU Huan-gan, ZHANG Wei, ZHAO
Chen, LIU Hui-rong, GUO Lan-qin, WU Bei-ling, YU
Ai-zhen, ZHANG Ying-ying, Shanghai University of TCM,
Shanghai 201203, China
Supported by National Basic Research Program of China
(973 program), No. 2009CB522900; National Natural Science
Foundation of China, No. 30701124; Nanjing University of
Chinese Medicine, Key laboratory of Acupuncture Com-
bined with Medication, NO.KJA200914
Correspondence to: Prof. Wu Huan-gan, Shanghai Univer-
sity of TCM, Shanghai 201203, China. wuhuangan@126.com
Telephone: +86-21-64644238
Accepted: October 21, 2011
Abstract
OBJECTIVE: To explore the anti-aging effects of
mild-warming moxibustion on Bcl-2 and PKC ex-
pression in peripheral blood and general symp-
toms in elderly people.
METHODS: A total of 61 elderly people and 30
non-elderly people were enrolled. The total effec-
tive rate of mild-warming moxibustion was as-
sessed by symptom scores, and Bcl-2 and PKC ex-
pression in peripheral blood was detected by flow
cytometry.
RESULTS: The total effective rate in the mild-warm-
ing moxibustion group was significantly higher
than in the blank control group (P＜0.01). Bcl-2 and
PKC expression rates in peripheral blood in the
blank control group were lower than in the normal
control group (P＜0.01), but higher after
mild-warming moxibustion (P＜0.01).
CONCLUSION: The anti-aging effects of mild-warm-
ing moxibustion may be due to increased Bcl-2 and
PKC expression in peripheral blood in aged people.
© 2012 JTCM. All rights reserved.
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INTRODUCTION
The aging population has significantly influenced eco-
nomic growth and medical care. Thus, delaying the ag-
ing process has become an important focus. Moxibus-
tion has advantages in delaying aging and has been con-
sidered an important method for protecting health. It
has proven to play a favorable role in regulating the im-
mune and endocrine systems and in regulating free rad-
icals in the elderly[1-5].Mild-warming is one kind of mox-
ibustion, indicated for insomnia, chronic visceral hyper-
algesia and infertility due to ovulatory disturbance[6-8].
The procedure is to suspend the ignited moxa roll over
the acupoint for 10–15 min until there is local skin
blush, but no pain. In the present study we selected
Shenshu (BL 23) and Guanyuan (CV 4) as the effec-
tive points[9-10]. Many researchers have confirmed the
anti-aging effects of Shenshu (BL 23) and Guanyuan
(CV 4), which work by regulating free radicals, the im-
mune system and endocrine function[11-22]. We mea-
sured the expression of proteins Bcl-2 (B cell lympho-
ma gene-2) and PKC (protein kinase C) in peripheral
blood of elderly people by flow cytometry so as to pro-
vide scientific evidence for using mild-warming moxi-
bustion to prevent and delay the aging process. This
study was approved by the appropriate ethics commit-
tees and was performed in accordance with the ethical
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standards laid down in the Declaration of Helsinki. All
persons signed their informed consent prior to their in-
clusion in the study.
CLINICALMATERIALS
General Data
A total of 91 subjects, including 61 elderly and 30
non-edlerly participants, were enrolled in the study
from September 2006 to April 2007. The elderly were
from Shaxiyuan Community of Shanghai, aged 60–
75 years, who were free of cardiac, cerebral, pulmo-
nary, hepatic, renal and endocrine diseases, and were
randomly divided into the mild-warming moxibustion
group (n=31) and the blank control group (n=30). In
the mild-warming moxibustion group, 10 were male
(32.3%) and 21 female (67.7%), aged between 60 and
75 years, with an average age of 68.48±5.32. The aver-
age score of aging symptoms was 40.13±3.62, ranging
from 33 to 46. In the blank control group, 12 were
male (40.0% ) and 18 female (60.0% ), aged between
60 to 75 years, with an average age of 67.70±4.91. The
average score of aging symptoms was 38.80±3.46, rang-
ing from 34 to 45. There were no statistically signifi-
cant differences in gender, age and the aging symptom
score before treatment between the two groups (P>
0.05). The normal control group included 30 non-el-
derly healthy participants aged 25–35 years.
Diagnostic Standards
Elderly people aged from 60 to 75 were selected accord-
ing to the standards in Guiding Principles for Clinical
Research on Anti-aging Drugs issued by the Ministry
of Health of China[23], which is also based on the classi-
fication criteria for elderly people proposed by the
World Health Organization (WHO).
TCM Syndrome Differentiation
All elderly subjects had symptoms and signs of kid-
ney-yang deficiency, manifested by flaccidity in loins
and knees, aversion to cold, frequent nocturia, lassi-
tude, shortness of breath, loose bowel, loss of hair or
graying hair, forgetfulness, loose teeth, decreased sexual
desire, edema in the cheeks and eyelids, pale, fat and
moist tongue with white-thick coating, and deep-slow
pulse with a special weakness in bilateral chi-pulses.
METHODS
Therapeutic Method
The 61 elderly subjects were divided into mild-warm-
ing moxibustion group and blank control groups by
random number table. The normal control group con-
sisted of 30 normal adolescents. For the mild-warming
moxibustion group (n=31), the suspended moxibus-
tion treatment was performed at Shenshu (BL 23) and
Guanyuan (CV 4). The two Shenshu (BL 23) acu-
points were chosen alternately in combination with
Guanyuan (CV 4) point; each treatment lasting 20
min, three times per week, and with 18 sessions mak-
ing up one treatment course. Changes in clinical symp-
toms were observed after the first treatment course.
Changes in clinical symptoms were observed and the
laboratory indexes were measured again after the sec-
ond treatment course. The blank control group (n=30)
received no treatments. Normal control group (n=30)
received no treatments.
Observation of Aging Symptoms
Table 1 shows the aging symptoms according to kid-
ney-yang deficiency in the syndrome differentiation for
aging found in Appendix 1 of the Screening Proce-
dures and Standards of Clinical Observations of An-
ti-aging Chinese Herbs drawn up by the Third Nation-
al Conference of the Coordinative Study Group of Inte-
grated Traditional and Western Medicine for the Elder-
ly[24].
Table 1 Syndrome of Kidney-Yang Deficiency
Syndrome
Kidney-
Yang
Deficiency
Inspection, Pulse Palpation
1) Edema in Cheeks and Eyelids;
2) Pale, Fat and Moist Tongue proper
with White-Thick Coating; 3)
Deep-slow Pulse, Weak in Chi-pulse.
Inquiry
Main Symptoms
1) Flaccidity in Loins
and Knees;
2) Extreme Chilliness.
Secondary Symptoms
1) Frequent Nocturia; 2) Llassitude; 3) Shortness of
Breath; 4) Loose Stool; 5) Graying Hair or Hair
Loss; 6) Forgetfulness; 7) Loose Teeth; 8) Decreased
Sexual Desire.
Table 2 The therapeutic effects
Groups
Mild-warming Moxibustion Group
Blank Control Group
n
31
30
Marked Effect
1
0
Improvement
26
3
Failure
4
27
Effective Rate (%)
87.10﹡﹡
10.00
Note: As compared with the blank control group.﹡﹡P<0.01.
Scoring Standards of the Clinical Symptoms
Assessment of clinical symptoms was based on the as- sessment method for scoring aging symptoms in the ap-
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pendix of the Screening Procedures and Standards of
Clinical Observations of Anti-aging Chinese Herbs
drawn up by the Third National Conference of the Co-
ordinative Study Group of Integrated Traditional and
Western Medicine for the Elderly[24], as well as accord-
ing to the criteria of scoring aging symptoms in the
clinical assessment for anti-aging drugs of the Modern
Pharmaceutics for the Elderly[25]. The final aging score
was the cumulative score for each of the single symp-
toms.
Inquiry: All participants were asked the same ques-
tions. A score of 4 would be given if the symptom was
volunteered; the score was 3 if the symptom was ob-
tained by inquiry and the symptom occurred signifi-
cantly or continuously; symptoms which were paroxys-
mal or unstable were scored 2; if the symptoms were
mild or appeared occasionally, the score would be 1;
the score would be 0 if there were no symptoms.
Inspection and pulse palpation: A score of 6 was given
if each of the symptoms existed.
For assessment of the aging symptoms of kidney-yang
deficiency, the patient had to have two of the main
symptoms, 3 of the secondary symptoms, and 1 symp-
tom each, in the inspection and pulse palpation, with a
total score ≥ 13.
Standard for Therapeutic Effects
This was according to the therapeutic effect criteria in
appendix 2 of the Screening Procedures and Standards
of Clinical Observations of Anti-aging Chinese Herbs
drawn up by the Third National Conference of the Co-
ordinative Study Group of Integrated Traditional and
Western Medicine for the Elderly[24]. Marked effect: the
aging score after treatment was reduced by > 2/3. Im-
provement: the post-treatment aging score was de-
creased by 1/3–2/3. Failure: the post-treatment aging
score was reduced by <1/3.
Detection of Bcl-2 and PKC Expression
At the end of the second treatment course, a fasting pe-
ripheral blood sample was collected and the expression
of Bcl-2 and PKC was detected by flow cytometry.
According to protocol, 10 µL CD45-PC5 was added
to 50 µL heparin-anticoagulated peripheral blood and
incubated for 15 min at room temperature, then agitat-
ed and mixed with 100 µL of IntraPrep Reagent 1 and
incubated for another 15 min at room temperature
away from light. Afterwards, 4 mL of PBS-BSA was
added and the sample centrifuged at 300 g/min for 5
min, discarding the supernatant. Next, 100 µL of Intra-
Prep Reagent 2 was added, mixed gently and incubated
at room temperature for 5 min away from light. The
primary antibody was added by corresponding dosage,
gently mixed until homogeneous, and incubated for 20
min at room temperature away from light. Four mL of
PBS-BSA was added and the supernatant was discard-
ed following centrifugation for 5 min at 300 g/min.
One mL of PBS-BSA was added and resuspended be-
fore examination if direct fluorescent staining was posi-
tive. If indirect fluorescent staining occurred, 2 µL of
secondary IgG-FITC antibody was added, gently
mixed until homogeneous, and incubated at room tem-
perature for 20 min away from light. Four mL of
PBS-BSA was added and the supernatant was discard-
ed after centrifugation for 5 min at 300 g/min. One
mL of PBS-BSA was added and the sample resuspend-
ed, then examined for Bcl-2 and PKC expression.
For the control group, CD45-PC5 was added but with
no antibodies. For the blank group, CD45-PC5 and
the second antibody or IgG1 (mouse) – FITC was
added.
Statistical Method
SPSS11.0 software was used for statistical processing.
The measurement data were assessed using t-tests and
the categorical data were assessed by Chi-square tests.
The percentage of cells in each stage of the cell cycle
was expressed as ( xˉ ±s)%, and assessed using one-way
ANOVA. The Kruskal-Wallis test was used if values
were not in accord with the conditions of ANOVA.
RESULTS
Therapeutic Effects
As shown in Table 2, in the 31 participants in the
mild-warming moxibustion group, 1 obtained a
marked effect, 26 improvement, and 4 showed failure;
with a total effective rate of 87.10%. Of the 30 partici-
pants in the blank control group, no participants ob-
tained a marked effect; 3 improvement; 27 no improve-
ment; with a total effective rate of 10.00%. There was
a statistically significant difference between the two
groups (P<0.01).
The Effect of Mild-warming Moxibustion on Bcl-2
Expression in Peripheral Blood in the Aged
As shown in Table 3, the Bcl-2 expression rate in pe-
ripheral blood in the aged was significantly lower than
in the normal control group (P<0.01). There was a sig-
nificantly higher Bcl-2 expression rate in the
mild-warming moxibustion group than in the blank
control group (P<0.01).
The Effect of Mild-warming Moxibustion on PKC Ex-
pression in Peripheral Blood in the Aged
As shown in Table 4, the PKC expression rate in pe-
ripheral blood in the aged was significantly lower than
in the normal control group (P＜0.01). There was a
significantly higher PKC expression rate in the
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mild-warming moxibustion group than in the blank
control group (P＜0.01).
Table 3 The Bcl-2 expression rate in peripheral blood in
each of the groups ( xˉ ±S)%.
Groups
Blank control group
Mild-warming
moxibustion group
Normal control group
N
30
31
30
Positive expression of
protein Bcl-2 (%)
33.45 ± 4.04 **
41.75 ± 3.23 **ΔΔ
59.95 ± 7.14
Note: Compared with the normal control group, **P<0.01; com-
pared with the blank control group, ΔΔP<0.01.
Table 4 The PKC expression rate in peripheral blood in each
of the groups ( xˉ ±S)%.
Groups
Blank control group
Mild-warming
moxibustion group
Normal control group
N
30
31
30
Positive expression of
protein PKC (%)
3.29±2.29**
22.78±6.30**ΔΔ
38.68±6.42
Note: Compared with the normal control group, **P<0.01; com-
pared with the blank control group, ΔΔP<0.01.
DISCUSSION
Telomerase, an RNA-directed DNA polymerase that
may extend telomeres of eukaryotic chromosomes,
plays an important role in aging and anti-aging[26-36],
which is a new important highlight in the genetic pro-
gram of aging. Several proto-oncogenes and tumor sup-
pressor genes are implicated in the regulation of telom-
erase activity, including Bcl-2 and PKC[37-40]. B cell lym-
phoma gene-2 (Bcl-2) is an important anti-apoptotic
gene, residing at human chromosome 18q21, and con-
taining three exons, 230 kb in length. Gene Bcl-2 en-
codes a protein of 25– 26 KD Previous studies re-
vealed that Bcl-2 usually resides in the mitochondria,
endoplasmic reticulum, and nuclear membrane where
a high number of oxygen free radicals are produced, re-
lated to anti-oxidation and self-protection of the cells.
Bcl-2 is also call "the longevity gene", for its resistance
to apoptosis induced by various stimuli, and is a com-
mon index adopted to detect aging[41]. The expression
of Bcl-2 is decreased in aged cells[42-51]. Some experi-
ments have demonstrated that Bcl-2 may prolong the
life of many types of hematopoietic growth factors[52].
Protein kinase C (PKC) is a type of Ca2 + phospholip-
id-dependent protein kinase, involved in the modula-
tion of cell actions[53]. Activated PKC can phosphory-
late Ser or Thr residues in protein substrates, and is
one of the important molecules in the signal pathway.
A number of experiments have implied that dysfunc-
tion of PKC plays a decisive role in the development
and process of senescence in aged cells[54-64]. PKC is
widely distributed in the organs, tissues and cells of
mammals, influencing the transmission of intracellular
biological signals, and plays an important role in the
modulation of cellular metabolism, differentiation, pro-
liferation and even apoptosis[65-69]. PKC is considered
one of the key molecules in intracellular signal trans-
mission, because it can activate target enzymes in the
cytoplasm to take part in the regulating of biochemical
reactions and it can also act on transcription factors in
the cell nucleus to modulate the expression of genes re-
lated to growth and differentiation of cells.
Previous research shows that high expression of Bcl-2
and PKC may raise telomerase activity, and PKC may
promote Bcl–2 expression. Telomerase activity can be
adjusted by PKC through effecting hTERT expres-
sion[70]. Mitochondrial apoptosis induced by hTERT is
related to the inhibition of Bcl– 2 expression[71-72].
Bcl-2 and PKC may adjust telomerase activity alone or
synergistically.
In the present study, the anti-aging effects of
mild-warming moxibustion were observed by scoring
the general symptoms and detecting Bcl-2 and PKC ex-
pression in peripheral blood in the aged. The results
showed that the total effective rate was higher in the
mild-warming moxibustion group than in the blank
control group (P<0.01); Bcl-2 and PKC expression
rates in peripheral blood were lower in the blank con-
trol group than in the normal control group; while
they were higher in the mild-warming moxibustion
group than in the blank control group. Mild-warming
moxibustion may delay the aging process by increasing
Bcl-2 and PKC expression in peripheral blood in the
aged. Therefore, mild-warming moxibustion is worth
popularization in clinics. However, the relationship of
the relevant indexes with the anti-aging effects of
mild-warming moxibustion and the molecular mecha-
nisms involved needs further study.
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